Unstable Ischemic Syndromes: Acute Therapy and Long-Term Outcomes
Monday, April 4, 2:00-3:30 PM
In this Oral Contributions session, lecturers will cover a wide-spectrum of topics associated with coronary interventions. It's always a good idea for attendees of the ACC meeting to take in oral contribution sessions, as they hint at potential practice-changing protocols.
In this session, for example, researchers combed the ACC NCDR PCI registry to better understand the high mortality rate in those with left-dominant coronary artery circulation undergoing PCI. This registry has already provided valuable data on many variables associated with PCI. And as more and more researchers begin to investigate its data, the results will go a long way to better inform clinical practice.
Also in this session, HORIZONS-AMI researchers will detail their substudy that looked at the impact of chronic kidney disease on PCI outcomes. There are many associated comorbidities that impact coronary interventions and kidney disease is one of the most challenging.
The abstract presented in this session will help interventional cardiologists better understand particular patient populations. And that is the direction of medicine in general: more personalized care. With various devices and drug regimens, interventionalists can better tailor treatment so that outcomes are optimized.
Speaker Information
In this Oral Contributions session, lecturers will cover a wide-spectrum of topics associated with coronary interventions. It's always a good idea for attendees of the ACC meeting to take in oral contribution sessions, as they hint at potential practice-changing protocols.
In this session, for example, researchers combed the ACC NCDR PCI registry to better understand the high mortality rate in those with left-dominant coronary artery circulation undergoing PCI. This registry has already provided valuable data on many variables associated with PCI. And as more and more researchers begin to investigate its data, the results will go a long way to better inform clinical practice.
Also in this session, HORIZONS-AMI researchers will detail their substudy that looked at the impact of chronic kidney disease on PCI outcomes. There are many associated comorbidities that impact coronary interventions and kidney disease is one of the most challenging.
The abstract presented in this session will help interventional cardiologists better understand particular patient populations. And that is the direction of medicine in general: more personalized care. With various devices and drug regimens, interventionalists can better tailor treatment so that outcomes are optimized.
Speaker Information
- Nisha I. Parikh, MD, et al, Harvard Beth Israel Deaconess Medical Center, Boston -- Left-Dominant Coronary Artery Circulation Is Associated with Higher In-Hospital Mortality among Patients undergoing Percutaneous Coronary Intervention in Acute Coronary Syndrome: Data from the American College of Cardiology National Cardiovascular Data Registry for Catheterization Percutaneous Coronary Intervention
- Adam J. Saltzman, MD, et al, Cardiovascular Research Foundation, New York City -- Impact of Chronic Kidney Disease on Long-Term Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention and Alternative Antithrombotic Treatment Strategies: A HORIZONS-AMI Substudy
- Chee Tang Chin, MD, et al, National Heart Centre Singapore -- Comparison of Trends in In-Hospital and Long-Term Outcomes over Time among Older Patients with Non-ST-Segment Elevation Myocardial Infarction: Insights from the CRUSADE Quality Improvement Registry
- Marc P. Bonaca, MD, et al, Brigham and Women's Hospital, Boston -- Long-Term Thienopyridine Therapy and Outcomes in Patients with ACS Treated with Coronary Stenting: The Primary Results of the TIMI-38 Coronary Stent Registry
- Zhijing Zhao, MD, et al, Columbia University Medical Center, New York City -- Dynamic Nature of Non-Culprit Coronary Artery Lesion Morphology in ST-Segment Elevation Myocardial Infarction Patients: A Serial Virtual Histology-Intravascular Ultrasound Analysis from the HORIZONS-Acute Myocardial Infarction Trial